Andrew Huberman has built a significant online following by providing practical health advice based on scientific research. He covers topics such as sleep, fitness, hormones, supplements, and longevity. As a neuroscientist and podcaster at Stanford, Huberman is now taking a more active role in consumer health by joining the board of Hims & Hers. This telehealth company is expanding its services from hair loss and erectile dysfunction into weight loss, testosterone, preventive care, and peptides.
Huberman will also advise Hims & Hers on science and brand marketing strategies. He insists that his association with the company will not influence his content. Huberman stated, “We will never filter information differently because of a brand relationship.” This ensures transparency and reliability in his coverage.
Joining Huberman on the board are former Netflix CFO David Wells and former DoorDash CFO Kofi Amoo-Gottfried. Huberman’s podcast and YouTube channel reach millions monthly, connecting him to a company that can supply many treatments he discusses.
Huberman views his board role as a chance to have a direct impact on healthcare. He emphasizes shared goals with Hims CEO Andrew Dudum, to make healthcare practices widely accessible. Dudum and Huberman aim to bridge the gap between conventional healthcare and high-end concierge care.
Many telehealth companies are targeting this middle ground in healthcare, including Ro and Midi. Hims stands out due to its large customer base and infrastructure, including a pharmacy and manufacturing capabilities. By partnering with Huberman, Hims can reach a wider audience.
Notably, Huberman’s role coincides with Hims’ expansion into areas like testosterone and peptides. These areas are gaining mainstream attention. Hims invested in a California peptide facility, reflecting its commitment to this segment. Peptides such as BPC-157 will be available through the Peptides+ section of their site, pending regulatory approval.
Huberman expresses caution in promoting peptides, noting, “I don’t know if somebody without an injury needs BPC and TB-500.” Nonetheless, he supports Hims’ comprehensive approach to peptide manufacturing and regulatory compliance.
Huberman aims to maintain editorial independence on his podcast. His channel boasts over 8 million subscribers, consistently ranking among the top health podcasts. He promises that information will remain unbiased, saying, “We will never filter information differently because of a brand relationship.” Hims encourages Huberman to keep educating independently of any products.
The collaboration suggests that Hims can provide consumers with informed choices amidst the vast wellness information landscape. The challenge lies in maintaining rigor, given Huberman’s dual roles in directing and marketing services.
